Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis
| Autor: | Šťastná-Marková, Markéta a, Pecherková, Pavla b, Němečková, Šárka c, Kryštofová, Jitka c, Vaníková, Šárka d, Vydra, Jan a, Roubalová, Kateřina c, ⁎ |
|---|---|
| Zdroj: | In Transplant Immunology December 2024 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect